Cargando…

Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis

BACKGROUND: Metastatic colonization is one of the critical steps in tumor metastasis. A pre-metastatic niche is required for metastatic colonization and is determined by tumor-stroma interactions, yet the mechanistic underpinnings remain incompletely understood. METHODS: PCR-based miRNome profiling,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Yulan, Leung, Leanne L., Mak, Celia S. L., Wang, Xueyu, Chan, Wai-Sun, Hui, Lynn M. N., Tang, Hermit W. M., Siu, Michelle K. Y., Sharma, Rakesh, Xu, Dakang, Tsui, Stephen K. W., Ngan, Hextan Y. S., Yung, Mingo M. H., Chan, Karen K. L., Chan, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827705/
https://www.ncbi.nlm.nih.gov/pubmed/36624516
http://dx.doi.org/10.1186/s12943-022-01703-9
_version_ 1784867104689750016
author Mo, Yulan
Leung, Leanne L.
Mak, Celia S. L.
Wang, Xueyu
Chan, Wai-Sun
Hui, Lynn M. N.
Tang, Hermit W. M.
Siu, Michelle K. Y.
Sharma, Rakesh
Xu, Dakang
Tsui, Stephen K. W.
Ngan, Hextan Y. S.
Yung, Mingo M. H.
Chan, Karen K. L.
Chan, David W.
author_facet Mo, Yulan
Leung, Leanne L.
Mak, Celia S. L.
Wang, Xueyu
Chan, Wai-Sun
Hui, Lynn M. N.
Tang, Hermit W. M.
Siu, Michelle K. Y.
Sharma, Rakesh
Xu, Dakang
Tsui, Stephen K. W.
Ngan, Hextan Y. S.
Yung, Mingo M. H.
Chan, Karen K. L.
Chan, David W.
author_sort Mo, Yulan
collection PubMed
description BACKGROUND: Metastatic colonization is one of the critical steps in tumor metastasis. A pre-metastatic niche is required for metastatic colonization and is determined by tumor-stroma interactions, yet the mechanistic underpinnings remain incompletely understood. METHODS: PCR-based miRNome profiling, qPCR, immunofluorescent analyses evaluated the expression of exosomal miR-141 and cell-to-cell communication. LC-MS/MS proteomic profiling and Dual-Luciferase analyses identified YAP1 as the direct target of miR-141. Human cytokine profiling, ChIP, luciferase reporter assays, and subcellular fractionation analyses confirmed YAP1 in modulating GROα production. A series of in vitro tumorigenic assays, an ex vivo model and Yap1 stromal conditional knockout (cKO) mouse model demonstrated the roles of miR-141/YAP1/GROα/CXCR1/2 signaling cascade. RNAi, CRISPR/Cas9 and CRISPRi systems were used for gene silencing. Blood sera, OvCa tumor tissue samples, and tissue array were included for clinical correlations. RESULTS: Hsa-miR-141-3p (miR-141), an exosomal miRNA, is highly secreted by ovarian cancer cells and reprograms stromal fibroblasts into proinflammatory cancer-associated fibroblasts (CAFs), facilitating metastatic colonization. A mechanistic study showed that miR-141 targeted YAP1, a critical effector of the Hippo pathway, reducing the nuclear YAP1/TAZ ratio and enhancing GROα production from stromal fibroblasts. Stromal-specific knockout (cKO) of Yap1 in murine models shaped the GROα-enriched microenvironment, facilitating in vivo tumor colonization, but this effect was reversed after Cxcr1/2 depletion in OvCa cells. The YAP1/GROα correlation was demonstrated in clinical samples, highlighting the clinical relevance of this research and providing a potential therapeutic intervention for impeding premetastatic niche formation and metastatic progression of ovarian cancers. CONCLUSIONS: This study uncovers miR-141 as an OvCa-derived exosomal microRNA mediating the tumor-stroma interactions and the formation of tumor-promoting stromal niche through activating YAP1/GROα/CXCRs signaling cascade, providing new insight into therapy for OvCa patients with peritoneal metastases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01703-9.
format Online
Article
Text
id pubmed-9827705
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98277052023-01-10 Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis Mo, Yulan Leung, Leanne L. Mak, Celia S. L. Wang, Xueyu Chan, Wai-Sun Hui, Lynn M. N. Tang, Hermit W. M. Siu, Michelle K. Y. Sharma, Rakesh Xu, Dakang Tsui, Stephen K. W. Ngan, Hextan Y. S. Yung, Mingo M. H. Chan, Karen K. L. Chan, David W. Mol Cancer Research BACKGROUND: Metastatic colonization is one of the critical steps in tumor metastasis. A pre-metastatic niche is required for metastatic colonization and is determined by tumor-stroma interactions, yet the mechanistic underpinnings remain incompletely understood. METHODS: PCR-based miRNome profiling, qPCR, immunofluorescent analyses evaluated the expression of exosomal miR-141 and cell-to-cell communication. LC-MS/MS proteomic profiling and Dual-Luciferase analyses identified YAP1 as the direct target of miR-141. Human cytokine profiling, ChIP, luciferase reporter assays, and subcellular fractionation analyses confirmed YAP1 in modulating GROα production. A series of in vitro tumorigenic assays, an ex vivo model and Yap1 stromal conditional knockout (cKO) mouse model demonstrated the roles of miR-141/YAP1/GROα/CXCR1/2 signaling cascade. RNAi, CRISPR/Cas9 and CRISPRi systems were used for gene silencing. Blood sera, OvCa tumor tissue samples, and tissue array were included for clinical correlations. RESULTS: Hsa-miR-141-3p (miR-141), an exosomal miRNA, is highly secreted by ovarian cancer cells and reprograms stromal fibroblasts into proinflammatory cancer-associated fibroblasts (CAFs), facilitating metastatic colonization. A mechanistic study showed that miR-141 targeted YAP1, a critical effector of the Hippo pathway, reducing the nuclear YAP1/TAZ ratio and enhancing GROα production from stromal fibroblasts. Stromal-specific knockout (cKO) of Yap1 in murine models shaped the GROα-enriched microenvironment, facilitating in vivo tumor colonization, but this effect was reversed after Cxcr1/2 depletion in OvCa cells. The YAP1/GROα correlation was demonstrated in clinical samples, highlighting the clinical relevance of this research and providing a potential therapeutic intervention for impeding premetastatic niche formation and metastatic progression of ovarian cancers. CONCLUSIONS: This study uncovers miR-141 as an OvCa-derived exosomal microRNA mediating the tumor-stroma interactions and the formation of tumor-promoting stromal niche through activating YAP1/GROα/CXCRs signaling cascade, providing new insight into therapy for OvCa patients with peritoneal metastases. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12943-022-01703-9. BioMed Central 2023-01-09 /pmc/articles/PMC9827705/ /pubmed/36624516 http://dx.doi.org/10.1186/s12943-022-01703-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Mo, Yulan
Leung, Leanne L.
Mak, Celia S. L.
Wang, Xueyu
Chan, Wai-Sun
Hui, Lynn M. N.
Tang, Hermit W. M.
Siu, Michelle K. Y.
Sharma, Rakesh
Xu, Dakang
Tsui, Stephen K. W.
Ngan, Hextan Y. S.
Yung, Mingo M. H.
Chan, Karen K. L.
Chan, David W.
Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis
title Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis
title_full Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis
title_fullStr Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis
title_full_unstemmed Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis
title_short Tumor-secreted exosomal miR-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis
title_sort tumor-secreted exosomal mir-141 activates tumor-stroma interactions and controls premetastatic niche formation in ovarian cancer metastasis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827705/
https://www.ncbi.nlm.nih.gov/pubmed/36624516
http://dx.doi.org/10.1186/s12943-022-01703-9
work_keys_str_mv AT moyulan tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT leungleannel tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT makceliasl tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT wangxueyu tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT chanwaisun tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT huilynnmn tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT tanghermitwm tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT siumichelleky tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT sharmarakesh tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT xudakang tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT tsuistephenkw tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT nganhextanys tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT yungmingomh tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT chankarenkl tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis
AT chandavidw tumorsecretedexosomalmir141activatestumorstromainteractionsandcontrolspremetastaticnicheformationinovariancancermetastasis